Hormone Replacement Therapy is Not a Risk for Venous Thrombosis

Bungay GT Vessey MP McPherson CK . Study of symptoms in middle life with special reference to the menopause. Br Med J 1980 ii, 181–183.

Wilkes HC Meade TW . Hormone replacement therapy in general practice: a survey of doctors in the MRC's general practice research framework. Br Med J 1991, 302. 1317–1320.

Kadri AZ . Hormone replacement therapy — A survey of pre-menopausal women in a community setting. British Journal of General Practice 1991 41, 109–112.

Consensus Development Conference: Prophylaxis and Treatment of Osteoporosis. Osteoporosis International 1991; 1, 114–117.

Barrett-Connor E Bush TL . Oestrogen and coronary heart disease in women. Journal of the American Medical Association 1991 265, 18611867.

Forbes CD . Hommone replacement therapy and future risks of arterial disease. Vascular Medicine Review 1993

Kay C. The Royal College of General Practitioners. Oral Contraception Study: Some recent observations. Clinical Obstetrics and Gynaecology 1984; 11, 759–786.

Vessey MD Villard-MacKintosh L MacPherson K Yeates D. Mortality among oral contraceptive users: 20 years follow-up of women in a cohort study. Br Med J 1989; 299, 1487–1491.

Meade TW Haines AP Imeson JD Stirling Y Thomson SG . Menopausal status and haemostatic variables. Lancet 1983; i, 22–24.

Meade TW Dyer S Howart DJ Stirling Y Antithrombin III and procoagulant activity: sex differences and effects ofthe menopause. British Journal of Haematology 1990; 74, 77–81.

Lindberg UB Crona N Stigendal L Teger-Nilsson AC Silferstolpe G. A comparison between effects of estradiol valerate and low dose estradiol on haemostasic parameters. Thrombosis and Haemostasis 1989; 61, 65

Winkler UH . Menopause hormone replacement therapy and cardiovascular disease: A review of the haemostaseological findings. Ageing and Fibnnolysis, Leiden, Netherlands 1992.

Steinleitner A Stanczyk FZ Lenn JH . Decreased in-vitro production of 6keto-prostaglandin by uterine arteries from post-menopausal women. American Journal of Obstetrics and Gynecology 1989, 161, 1677–1681.

De Lignieres B Basdevant A Thomas G. Biological effects of estradiol 176 in post-menopausal women: oral versus percutaneous administration Journal of Clinical Endocrinology and Metabolism 1986; 62, 536

Boston Collaborative Drug Surveillance Program. Surgically confirmed gallbladder disease, venous thromboembolism and breast tumours in relation to post menopausal oestrogen therapy. New England Journal of Medicine 1974, 290, 15–19.

Notelowitz M Ware M. Coagulation risks with post menopausal oestrogen therapy. Progress in Obstetrics and Gynaecology. Churchill Livingstone Edinburgh 1982; 228–240.

Whitehead M Godfree V In: Hormone Replacement Therapy. Churchill Livingstone 1992, p 13X–141.

Carter CJ . Thrombosis in relationship to oral contraceptives and hormone replacement therapy Turpie AGG Forbes CD (Eds) Haemostasis and Thrombosis in Obstetrics and Gynaecology London, Chapman Hall 1992; 371–388.

Johnsson H. Venous thrombosis, haemostasis and hommone replacement therapy. In: Cardiovascular Effects of Hormone Replacement Therapy Proceedings of the International Novo-Nordisk Symposium Copenhagen, Gladsaxe-Soeberg, Bogtrykkere Denmark 1992; 51–56.

Thrombembolic Risk Factors (THRIFT) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. British Medical Journal 1992; 305, 567–574.